Literature DB >> 8157049

Hepatic elimination of ACE inhibitors.

H Schulz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8157049     DOI： 10.1007/bf00315321

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.

Authors:  D A Sica; R E Cutler; R J Parmer; N F Ford
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

2.  Pharmacokinetics of temocapril hydrochloride, a novel angiotensin converting enzyme inhibitor, in renal insufficiency.

Authors:  M Nakashima; J Yamamoto; M Shibata; T Uematsu; H Shinjo; T Akahori; H Shioya; K Sugiyama; Y Kawahara
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Pharmacokinetics of fosinopril in patients with various degrees of renal function.

Authors:  K K Hui; K L Duchin; K J Kripalani; D Chan; P K Kramer; N Yanagawa
Journal:  Clin Pharmacol Ther       Date:  1991-04       Impact factor: 6.875
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.